Abiopharma

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0000950103-26-006659 <b>Size:</b> 431 KB

New Form NT 20-F - NATUZZI S P A <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0000900391-26-000008 <b>Size:</b> 62 KB

New Form PRER14A - Wave Life Sciences Ltd. <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001193125-26-201507 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001918704-26-011824 <b>Size:</b> 948 KB

Director Robinson Benjamin E III 🔴 sold 180 shares of WORLD ACCEPTANCE CORP (WRLD) at $160.00 Transaction Date: Apr 30, 2026 | Filing ID: 000002

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001213900-26-050972 <b>Size:</b> 3 MB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0000950103-26-006658 <b>Size:</b> 349 KB

New Form NPORT-P - GENERAL AMERICAN INVESTORS CO INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0002000324-26-001801 <b>Size:</b> 164 KB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001839882-26-022507 <b>Size:</b> 113 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001193125-26-201497 <b>Size:</b> 499 KB